British thoracic society guideline for non-CF bronchiectasis

Thorax

Volumn 65, Issue SUPPL. 1, 2010, Pages

  Pasteur, M C ^a   Bilton, D ^b   Hill, A T ^c  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MUCOLYTIC AGENT; XANTHINE; ANTIINFECTIVE AGENT; RESPIRATORY TRACT AGENT;

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BLOOD EXAMINATION; BRITISH THORACIC SOCIETY GUIDELINE; BRONCHIECTASIS; BRONCHOSCOPY; CILIARY MOTILITY; CLINICAL ASSESSMENT; CONGENITAL DISORDER; CORTICOSTEROID THERAPY; CYSTIC FIBROSIS; DISEASE EXACERBATION; DRUG INDICATION; DYSPNEA; ENTERITIS; FEVER; FIBROSIS; FOREIGN BODY ASPIRATION; HEMOPTYSIS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMIDIFIER; IMMUNE DEFICIENCY; IMMUNE FUNCTION TEST; LOWER RESPIRATORY TRACT INFECTION; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; MEDICAL PRACTICE; MYCOBACTERIUM TUBERCULOSIS; NONCYSTIC FIBROSIS; NURSING CARE; OUTCOME ASSESSMENT; OXYGEN THERAPY; PAIN; PATHOLOGY; PHYSIOTHERAPY; POSITIVE END EXPIRATORY PRESSURE; POSTURAL DRAINAGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIOLOGY; SPUTUM ANALYSIS; SYMPTOM; ADULT; CHILD; COMPUTER ASSISTED TOMOGRAPHY; EVIDENCE BASED MEDICINE; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NEBULIZER; RESPIRATORY TRACT EXAMINATION; REVIEW;

ADMINISTRATION, INHALATION; ADULT; ANTI-BACTERIAL AGENTS; BRONCHIECTASIS; CHILD; CYSTIC FIBROSIS; DIAGNOSTIC TECHNIQUES, RESPIRATORY SYSTEM; EVIDENCE-BASED MEDICINE; HUMANS; INFUSIONS, INTRAVENOUS; NEBULIZERS AND VAPORIZERS; PHYSICAL THERAPY MODALITIES; RESPIRATORY FUNCTION TESTS; RESPIRATORY SYSTEM AGENTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77955283910     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.136119     Document Type: Article

References (549)

1. Bass EM. Tracheobronchomegaly: the Mounier-Kuhn syndrome. S Afr Med J 1974;48:1718-20.
2. Bolman RM 3rd, Wolfe WG. Bronchiectasis and bronchopulmonary sequestration. Surg Clin North Am 1980;60:867-81.
3. Dakaraju P, Mansfield RE, Shatapathy P. Undiagnosed congenital oesophagobronchial fistulas in adults and older children. Accidental discovery under anaesthesia in cases of bronchiectasis. Anaesthesia 1974;29:169-74.
4. Danielson GK, Hanson CW, Cooper EC. Middle lobe bronchiectasis. Report of an unusual familial occurrence. JAMA 1967;201:605-8.
5. Davis PB, Hubbard VS, McCoy K, et al. Familial bronchiectasis. J Pediatr 1983;102:177-85.
6. Johnston RF, Green RA. Tracheobronchiomegaly. Report of five cases and demonstration of familial occurrence. Am Rev Respir Dis 1965;91:35-50.
7. Mitchell RE, Bury RG. Congenital bronchiectasis due to deficiency of bronchial cartilage (Williams-Campbell syndrome): a case report. J Pediatr 1975;87:230-4.
8. Nikolaizik WH, Warner JO. Aetiology of chronic suppurative lung disease. Arch Dis Child 1994;70:141-2.
9. Tang AT, Hulin SJ, Weeden DF. Surgical treatment for an unusual cause of localized bronchiectasis. Ann Thorac Surg 2000;69:1586-7.
10. Teoh PC. Bronchiectasis and spontaneous pneumothorax in Marfan's syndrome. Chest 1977;72:672-3.
11. Wayne KS, Taussig LM. Probable familial congenital bronchiectasis due to cartilage deficiency (Williams-Campbell syndrome). Am Rev Respir Dis 1976;114:15-22.
12. Williams H, Campbell P. Generalized bronchiectasis associated with deficiency of cartilage in the bronchial tree. Arch Dis Child 1960;35:182-91.
13. Ahel V, Zubovic I, Rozmanic V. Bronchial adenoid cystic carcinoma with saccular bronchiectasis as a cause of recurrent pneumonia in children. Pediatr Pulmonol 1992;12:260-2.
14. Akiyama K, Takizawa H, Suzuki M, et al. Allergic bronchopulmonary aspergillosis due to Aspergillus oryzae. Chest 1987;91:285-6.
15. Annobil SH, Morad NA, Kameswaran M, et al. Bronchiectasis due to lipid aspiration in childhood: clinical and pathological correlates. Ann Trop Paediatr 1996;16:19-25.
16. Box K, Kerr KM, Jeffrey RR, et al. Endobronchial lipoma associated with lobar bronchiectasis. Respir Med 1991;85:71-2.
17. Chiu FTS, Campbell H. Bronchogenic carcinoma causing non terminal saccular bronchiectasis. Aust N Z J Med 1973;3:200-3.
18. Døssing M, Khan JH. Nasal or oral oil application on infants: a possible risk factor for adult bronchiectasis. Eur J Epidemiol 1995;11:141-4.
19. Edwards EA, Asher MI, Byrnes CA. Paediatric bronchiectasis in the twenty-first century: experience of a tertiary children's hospital in New Zealand. J Paediatr Child Health 2003;39:111-17.
20. Glauser EM, Cook CD, Harris GB. Bronchiectasis: a review of 187 cases in children with follow-up pulmonary function studies in 58. Acta Paediatr Scand 1966;165:1+.
21. Mansour Y, Beck R, Danino J, et al. Resolution of severe bronchiectasis after removal of long-standing retained foreign body. Pediatr Pulmonol 1998;25:130-2.
22. Pasteur MC, Helliwell SM, Houghton SJ, et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 2000;162:1277-84.
23. Eastham KM, Fall AJ, Mitchell L, et al. The need to redefine non-cystic fibrosis bronchiectasis in childhood. Thorax 2004;59:324-7.
24. Lewiston NJ. Bronchiectasis in childhood. Pediatr Clin North Am 1984;31:865-78.
25. Hause DW, Harvey JC. Endobronchial carcinoid and mucoepidermoid carcinoma in children. J Surg Oncol 1991;46:270-2.
26. Hancock BJ, Di Lorenzo M, Youssef S, et al. Childhood primary pulmonary neoplasms. J Pediatr Surg 1993;28:1133-6.
27. Ozcelik U, Kotiloglu E, Gocmen A, et al. Endobronchial leiomyoma: a case report. Thorax 1995;50:101-2.
28. Tagge E, Yunis E, Chopyk J, et al. Obstructing endobronchial fibrous histiocytoma: potential for lung salvage. J Pediatr Surg 1991;26:1067-9.
29. Berman DE, Wright ES, Edstrom HW. Endobronchial inflammatory polyp associated with a foreign body. Successful treatment with corticosteroids. Chest 1984;86:483-4.
30. Williams HE, Phelan PD. The "missed" inhaled foreign body in children. Med J Aust 1969;1:625-8.
31. Slim MS, Yacoubian HD. Complications of foreign bodies in the tracheobronchial tree. Arch Surg 1966;92:388-93.
32. Limper AH, Prakash UB. Tracheobronchial foreign bodies in adults. Ann Intern Med 1990;112:604-9.
33. Ernst KD, Mahmud F. Reversible cystic dilatation of distal airways due to foreign body. South Med J 1994;87:404-6.
34. Baharloo F, Veyckemans F, Francis C, et al. Tracheobronchial foreign bodies: presentation and management in children and adults. Chest 1999;115:1357-62.
35. Debeljak A, Sorli J, Music E, et al. Bronchoscopic removal of foreign bodies in adults: experience with 62 patients from 1974-1998. Eur Respir J 1999;14:792-5.
36. Pitney AC, Callahan CW, Ruess L. Reversal of bronchiectasis caused by chronic aspiration in cri du chat syndrome. Arch Dis Child 2001;85:413-14.
37. Barker AF, Bardana EJ Jr. Bronchiectasis: update of an orphan disease. Am Rev Respir Dis 1988;137:969-78.
38. Reid KR, McKenzie FN, Menkis AH, et al. Importance of chronic aspiration in recipients of heart-lung transplants. Lancet 1990;336:206-8.
39. Valery PC, Torzillo PJ, Mulholland K, et al. Hospital-based case-control study of bronchiectasis in indigenous children in Central Australia. Pediatr Infect Dis J 2004;23:902-8.
40. Goudie BM, Kerr MR, Johnson RN. Mycoplasma pneumonia complicated by bronchiectasis. J Infect 1983;7:151-2.
41. Herbert FA, Wilkinson D, Burchak E, et al. Adenovirus type 3 pneumonia causing lung damage in childhood. Can Med Assoc J 1977;116:274-6.
42. Karakoc GB, Yilmaz M, Altintas DU, et al. Bronchiectasis: still a problem. Pediatr Pulmonol 2001;32:175-8.
43. Kaschula RO, Druker J, Kipps A. Late morphologic consequences of measles: a lethal and debilitating lung disease among the poor. Rev Infect Dis 1983;5:395-404.
44. Laraya Cuasay LR, DeForest A, Huff D, et al. Chronic pulmonary complications of early influenza virus infection in children. Am Rev Respir Dis 1977;116:617-25.
45. Massie R, Armstrong D. Bronchiectasis and bronchiolitis obliterans post respiratory syncytial virus infection: think again. J Paediatr Child Health 1999;35:497-8.
46. Nicotra MB, Rivera M, Dale AM, et al. Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. Chest 1995;108:955-61.
47. Parker EF, Brailsford LE, Gregg DB. Tuberculous bronchiectasis. Am Rev Respir Dis 1968;98:240-9.
48. Rosenzweig DY, Stead WW. The role of tuberculosis and other forms of bronchopulmonary necrosis in the pathogenesis of bronchiectasis. Am Rev Respir Dis 1966;93:769-85.
49. Scala R, Aronne D, Palumbo U, et al. Prevalence, age distribution and aetiology of bronchiectasis: a retrospective study on 144 symptomatic patients. Monaldi Arch Chest Dis 2000;55:101-5.
50. Simila S, Linna O, Lanning P, et al. Chronic lung damage caused by adenovirus type 7: a ten-year follow-up study. Chest 1981;80:127-31.
51. Lees AW. Atelectasis and bronchiectasis in pertussis. BMJ 1950;4689: 1138-41.
52. Warner WP. Factors causing bronchiectasis. JAMA 1935;104:1666-70.
53. Wynn-Williams N. Bronchiectasis: a study centred on Bedford and its environs. BMJ 1953;1:1194-9.
54. Kelly MG, Murphy S, Elborn JS. Bronchiectasis in secondary care: a comprehensive profile of a neglected disease. Eur J Intern Med 2003;14:488-92.
55. Noone PG, Leigh MW, Sannuti A, et al. Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med 2004;169:459-67.
56. Singleton R, Morris A, Redding G, et al. Bronchiectasis in Alaska native children: causes and clinical courses. Pediatr Pulmonol 2000;29:182-7.
57. Reich JM, Johnson RE. Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome. Chest 1992;101:1605-9.
58. Fowler SJ, French J, Screaton NJ, et al. Nontuberculous mycobacteria in bronchiectasis: Prevalence and patient characteristics. Eur Respir J 2006;28:1204-10.
59. Wickremasinghe M, Ozerovitch LJ, Davies G, et al. Non-tuberculous mycobacteria in patients with bronchiectasis. Thorax 2005;60:1045-51.
60. Ahn CH, McLarty JW, Ahn SS, et al. Diagnostic criteria for pulmonary disease caused by Mycobacterium kansasii and Mycobacterium intracellulare. Am Rev Respir Dis 1982;125:388-91.
61. Han XY, Tarrand JJ, Infante R, et al. Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare among patients without AIDS. J Clin Microbiol 2005;43:4407-12.
62. Bollert FG, Sime PJ, MacNee W, et al. Pulmonary Mycobacterium malmoense and aspergillus infection: a fatal combination? Thorax 1994;49:521-2.
63. Eijkhout HW, van Der Meer JW, Kallenberg CG, et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. Ann Intern Med 2001;135:165-74.
64. Roifman CM, Levison H, Gelfand EW. High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease. Lancet 1987;1:1075-7.
65. Bernatowska E, Madalinski K, Janowicz W, et al. Results of a prospective controlled two-dose crossover study with intravenous immunoglobulin and comparison (retrospective) with plasma treatment. Clin Immunol Immunopathol 1987;43:153-62.
66. Amorosa JK, Miller RW, Laraya Cuasay L, et al. Bronchiectasis in children with lymphocytic interstitial pneumonia and acquired immune deficiency syndrome. Plain film and CT observations. Pediatr Radiol 1992;22:603-6.
67. Bard M, Couderc LJ, Saimot AG, et al. Accelerated obstructive pulmonary disease in HIV infected patients with bronchiectasis. Eur Respir J 1998;11:771-5.
68. Barker AF, Craig S, Bardana EJ Jr. Humoral immunity in bronchiectasis. Ann Allergy 1987;59:179-82.
69. Chang AB, Masel JP, Boyce NC, et al. Non-CF bronchiectasis: clinical and HRCT evaluation. Pediatr Pulmonol 2003;35:477-83.
70. Chatila T, Wong R, Young M, et al. An immunodeficiency characterized by defective signal transduction in T lymphocytes. N Engl J Med 1989;320:696-702.
71. De Gracia J, Rodrigo MJ, Morell F, et al. IgG subclass deficiencies associated with bronchiectasis. Am J Respir Crit Care Med 1996;153:650-5.
72. Donato L, de la Salle H, Hanau D, et al. Association of HLA class I antigen deficiency related to a TAP2 gene mutation with familial bronchiectasis. J Pediatr 1995;127:895-900.
73. Hill SL, Mitchell JL, Burnett D, et al. IgG subclasses in the serum and sputum from patients with bronchiectasis. Thorax 1998;53:463-8.
74. Kearney PJ, Kershaw CR, Stevenson PA. Bronchiectasis in acute leukaemia. BMJ 1977;2:857-9.
75. Knowles GK, Stanhope R, Green M. Bronchiectasis complicating chronic lymphatic leukaemia with hypogammaglobulinaemia. Thorax 1980;35:217-18.
76. McGuinness G, Naidich DP, Garay S, et al. AIDS associated bronchiectasis: CT features. J Comput Assist Tomogr 1993;17:260-6.
77. Mehta VK, Massad MG, Tripathi SP, et al. Immune-deficient bronchiectasis associated with X-linked lymphoproliferative disease. Ann Thorac Surg 1999;68:578-80.
78. Miravitlles M, de Gracia J, Rodrigo MJ, et al. Specific antibody response against the 23-valent pneumococcal vaccine in patients with alpha(1)-antitrypsin deficiency with and without bronchiectasis. Chest 1999;116:946-52.
79. Morehead RS. Bronchiectasis in bone marrow transplantation. Thorax 1997;52:392-3.
80. Sansom ME, Ferry BL, Sherrell ZP, et al. A preliminary assessment of alpha-1 antitrypsin S and Z deficiency allele frequencies in common variable immunodeficiency patients with and without bronchiectasis. Clin Exp Immunol 2002;130:489-94.
81. Sheikh S, Madiraju K, Steiner P, et al. Bronchiectasis in pediatric AIDS. Chest 1997;112:1202-7.
82. Snowden N, Moran A, Booth J, et al. Defective antibody production in patients with rheumatoid arthritis and bronchiectasis. Clin Rheumatol 1999;18:132-5.
83. Stead A, Douglas JG, Broadfoot CJ, et al. Humoral immunity and bronchiectasis. Clin Exp Immunol 2002;130:325-30.
84. Verghese A.al Samman M, Nabhan D, et al. Bacterial bronchitis and bronchiectasis in human immunodeficiency virus infection. Arch Intern Med 1994;154:2086-91.
85. Watts WJ, Watts MB, Dai W, et al. Respiratory dysfunction in patients with common variable hypogammaglobulinemia. Am Rev Respir Dis 1986;134:699-703.
86. Pijnenburg MW, Cransberg K, Wolff E, et al. Bronchiectasis in children after renal or liver transplantation: a report of five cases. Pediatr Transplant 2004;8:71-4.
87. Holmes AH, Trotman-Dickenson B, Edwards A, et al. Bronchiectasis in HIV disease. Q J Med 1992;85:875-82.
88. van Kessel DA, van Velzen-Blad H, van den Bosch JM, et al. Impaired pneumococcal antibody response in bronchiectasis of unknown aetiology. Eur Respir J 2005;25:482-9.
89. Vendrell M, de Gracia J, Rodrigo MJ, et al. Antibody production deficiency with normal IgG levels in bronchiectasis of unknown etiology. Chest 2005;127:197-204.
90. Anon. Primary immunodeficiency diseases. Report of an IUIS Scientific Committee. International Union of Immunological Societies. Clin Exp Immunol 1999;118(Suppl 1):1-28.
91. Cunningham-Rundles C. Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J Clin Immunol 1989;9:22-33.
92. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999;92:34-48.
93. Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med 1993;86:31-42.
94. Martinez Garcia MA, de Rojas MD, Nauffal Manzur MD, et al. Respiratory disorders in common variable immunodeficiency. Respir Med 2001;95:191-5.
95. Spickett GP. Summary of antibody deficiency audit. CPD Bulletin Immunol Allergy 2000;1:58-61.
96. Thickett KM, Kumararatne DS, Banerjee AK, et al. Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. Q J Med 2002;95:655-62.
97. Gadola SD, Moins-Teisserenc HT, Trowsdale J, et al. TAP deficiency syndrome. Clin Exp Immunol 2000;121:173-8.
98. Solal-Celigny P, Couderc LJ, Herman D, et al. Lymphoid interstitial pneumonitis in acquired immunodeficiency syndrome-related complex. Am Rev Respir Dis 1985;131:956-60.
99. Stockley RA. Bronchiectasisenew therapeutic approaches based on pathogenesis. Clin Chest Med 1987;8:481-94.
100. Good RA, Mazzitello WF. Chest disease in patients with agammaglobulinemia. Dis Chest 1956;29:9-35.
101. Chapel HM. Consensus on diagnosis and management of primary antibody deficiencies. Consensus Panel for the Diagnosis and Management of Primary Antibody Deficiencies. BMJ 1994;308:581-5.
102. Notarangelo L, Casanova JL, Fischer A, et al. Primary immunodeficiency diseases: an update. J Allergy Clin Immunol 2004;114:677-87.
103. Busse PJ, Razvi S, Cunningham-Rundles C. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol 2002;109:1001-4.
104. Quartier P, Debre M, De Blic J, et al. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. J Pediatr 1999;134:589-96.
105. Koskinen S. Long-term follow-up of health in blood donors with primary selective IgA deficiency. J Clin Immunol 1996;16:165-70.
106. Schaffer FM, Monteiro RC, Volanakis JE, et al. IgA deficiency. Immunodefic Rev 1991;3:15-44.
107. Cunningham-Rundles C. Physiology of IgA and IgA deficiency. J Clin Immunol 2001;21:303-9.
108. Hanson LA, Soderstrom R, Nilssen DE, et al. IgG subclass deficiency with or without IgA deficiency. Clin Immunol Immunopathol 1991;61:S70-7.
109. Hammarstrom L, Vorechovsky I, Webster D. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 2000;120:225-31.
110. Levinson AI, Hopewell PC, Stites DP, et al. Coexistent lymphoid interstitial pneumonia, pernicious anemia, and agammaglobulinemia. Arch Intern Med 1976;136:213-16.
111. Nahm MH, Macke K, Kwon OH, et al. Immunologic and clinical status of blood donors with subnormal levels of IgG2. J Allergy Clin Immunol 1990;85:769-77.
112. Buckley RH. Immunoglobulin G subclass deficiency: fact or fancy? Curr Allergy Asthma Rep 2002;2:356-60.
113. Blore J, Haeney MR. Primary antibody deficiency and diagnostic delay. BMJ 1989;298:516-17.
114. Sweinberg SK, Wodell RA, Grodofsky MP, et al. Retrospective analysis of the incidence of pulmonary disease in hypogammaglobulinemia. J Allergy Clin Immunol 1991;88:96-104.
115. Roifman CM, Gelfand EW. Replacement therapy with high dose intravenous gamma-globulin improves chronic sinopulmonary disease in patients with hypogammaglobulinemia. Pediatr Infect Dis J 1988;7(5 Suppl):S92-6.
116. Kainulainen L, Varpula M, Liippo K, et al. Pulmonary abnormalities in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol 1999;104:1031-6.
117. Couriel J. Assessment of the child with recurrent chest infections. Br Med Bull 2002;61:115-32.
118. Bokszczanin A, Levinson AI. Coexistent yellow nail syndrome and selective antibody deficiency. Ann Allergy Asthma Immunol 2003;91:496-500.
119. Lederman HM, Winkelstein JA. X-linked agammaglobulinemia: an analysis of 96 patients. Medicine (Baltimore) 1985;64:145-56.
120. Kainulainen L, Nikoskelainen J, Vuorinen T, et al. Viruses and bacteria in bronchial samples from patients with primary hypogammaglobulinemia. Am J Respir Crit Care Med 1999;159:1199-204.
121. Spickett GP, Misbah SA, Chapel HM. Primary antibody deficiency in adults. Lancet 1991;337:281-4.
122. Angus RM, Davies ML, Cowan MD, et al. Computed tomographic scanning of the lung in patients with allergic bronchopulmonary aspergillosis and in asthmatic patients with a positive skin test to Aspergillus fumigatus. Thorax 1994; 49:586-9.
123. Bahous J, Malo JL, Paquin R, et al. Allergic bronchopulmonary aspergillosis and sensitization to Aspergillus fumigatus in chronic bronchiectasis in adults. Clin Allergy 1985;15:571-9.
124. Greenberger PA, Miller TP, Roberts M, et al. Allergic bronchopulmonary aspergillosis in patients with and without evidence of bronchiectasis. Ann Allergy 1993;70:333-8.
125. Mitchell TA, Hamilos DL, Lynch DA, et al. Distribution and severity of bronchiectasis in allergic bronchopulmonary aspergillosis (ABPA). J Asthma 2000;37:65-72.
126. Neeld DA, Goodman LR, Gurney JW, et al. Computerized tomography in the evaluation of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1990;142:1200-5.
127. Elliott MW, Newman Taylor AJ. Allergic bronchopulmonary aspergillosis. Clin Exp Allergy 1997;27(Suppl 1):55-9.
128. Greenberger PA. Allergic bronchopulmonary aspergillosis, allergic fungal sinusitis, and hypersensitivity pneumonitis. Clin Allergy Immunol 2002;16:449-68.
129. Phelan MS, Kerr IH. Allergic broncho-pulmonary aspergillosis: the radiological appearance during long-term follow-up. Clin Radiol 1984;35:385-92.
130. Hinson KF, Moon AJ, Plummer NS. Broncho-pulmonary aspergillosis; a review and a report of eight new cases. Thorax 1952;7:317-33.
131. Wang JL, Patterson R, Rosenberg M, et al. Serum IgE and IgG antibody activity against Aspergillus fumigatus as a diagnostic aid in allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1978;117:917-27.
132. Lee YM, Park JS, Hwang JH, et al. High-resolution CT findings in patients with near-fatal asthma: comparison of patients with mild-to-severe asthma and normal control subjects and changes in airway abnormalities following steroid treatment. Chest 2004;126:1840-8.
133. Vignola AM, Paganin F, Capieu L, et al. Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD. Eur Respir J 2004;24:910-17.
134. Bumbacea D, Campbell D, Nguyen L, et al. Parameters associated with persistent airflow obstruction in chronic severe asthma. Eur Respir J 2004;24:122-8.
135. Takemura M, Niimi A, Minakuchi M, et al. Bronchial dilatation in asthma: relation to clinical and sputum indices. Chest 2004;125:1352-8.
136. Awadh N, Muller NL, Park CS, et al. Airway wall thickness in patients with near fatal asthma and control groups: assessment with high resolution computed tomographic scanning. Thorax 1998;53:248-53.
137. Gono H, Fujimoto K, Kawakami S, et al. Evaluation of airway wall thickness and air trapping by HRCT in asymptomatic asthma. Eur Respir J 2003;22:965-71.
138. Grenier P, Mourey-Gerosa I, Benali K, et al. Abnormalities of the airways and lung parenchyma in asthmatics: CT observations in 50 patients and inter- and intraobserver variability. Eur Radiol 1996;6:199-206.
139. Paganin F, Seneterre E, Chanez P, et al. Computed tomography of the lungs in asthma: influence of disease severity and etiology. Am J Respir Crit Care Med 1996;153:110-14.
140. Paganin F, Trussard V, Seneterre E, et al. Chest radiography and high resolution computed tomography of the lungs in asthma. Am Rev Respir Dis 1992; 146:1084-7.
141. Lynch DA, Newell JD, Tschomper BA, et al. Uncomplicated asthma in adults: comparison of CT appearance of the lungs in asthmatic and healthy subjects. Radiology 1993;188:829-33.
142. Kasahara K, Shiba K, Ozawa T, et al. Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma. Thorax 2002;57:242-6.
143. Park JW, Hong YK, Kim CW, et al. High-resolution computed tomography in patients with bronchial asthma: correlation with clinical features, pulmonary functions and bronchial hyperresponsiveness. J Investig Allergol Clin Immunol 1997;7:186-92.
144. Little SA, Sproule MW, Cowan MD, et al. High resolution computed tomographic assessment of airway wall thickness in chronic asthma: reproducibility and relationship with lung function and severity. Thorax 2002;57:247-53.
145. Palwatwichai A, Chaoprasong C, Vattanathum A, et al. Clinical, laboratory findings and microbiologic characterization of bronchiectasis in Thai patients. Respirology 2002;7:63-6.
146. Ryu JH, Myers JL, Swensen SJ. Bronchiolar disorders. Am J Respir Crit Care Med 2003;168:1277-92.
147. Girodon E, Cazeneuve C, Lebargy F, et al. CFTR gene mutations in adults with disseminated bronchiectasis. Eur J Hum Genet 1997;5:149-55.
148. Ninis VN, Kýlýnç MO, Kandemir M, et al. High frequency of T9 and CFTR mutations in children with idiopathic bronchiectasis. J Med Genet 2003;40:530-5.
149. Pignatti PF, Bombieri C, Marigo C, et al. Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchiectasis. Hum Mol Genet 1995;4:635-9.
150. Tzetis M, Efthymiadou A, Strofalis S, et al. CFTR gene mutations - including three novel nucleotide substitutions - and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease. Hum Genet 2001;108:216-21.
151. Verra F, Escudier E, Bignon J, et al. Inherited factors in diffuse bronchiectasis in the adult: a prospective study. Eur Respir J 1991;4:937-44.
152. Hubert D, Fajac I, Bienvenu T, et al. Diagnosis of cystic fibrosis in adults with diffuse bronchiectasis. J Cyst Fibros 2004;3:15-22. (Pubitemid 38397019)
153. King PT, Freezer NJ, Holmes PW, et al. Role of CFTR mutations in adult bronchiectasis. Thorax 2004;59:357-8.
154. Casals T, De-Gracia J, Gallego M, et al. Bronchiectasis in adult patients: an expression of heterozygosity for CFTR gene mutations? Clin Genet 2004;65:490-5.
155. Divac A, Nikolic A, Mitic-Milikic M, et al. CFTR mutations and polymorphisms in adults with disseminated bronchiectasis: a controversial issue. Thorax 2005;60:85.
156. Stewart B, Zabner J, Shuber AP, et al. Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis. Am J Respir Crit Care Med 1995;151:899-903.
157. Gilljam M, Ellis L, Corey M, et al. Clinical manifestations of cystic fibrosis among patients with diagnosis in adulthood. Chest 2004;126:1215-24.
158. Swinson DR, Symmons D, Suresh U, et al. Decreased survival in patients with coexistent rheumatoid arthritis and bronchiectasis. Br J Rheumatol 1997;36:689-91.
159. McMahon MJ, Swinson DR, Shettar S, et al. Bronchiectasis and rheumatoid arthritis: a clinical study. Ann Rheum Dis 1993;52:776-9.
160. Allain J, Saraux A, Guedes C, et al. Prevalence of symptomatic bronchiectasis in patients with rheumatoid arthritis. Rev Rhum Engl Ed 1997;64:531-7.
161. Andonopoulos AP, Yarmenitis S, Georgiou P, et al. Bronchiectasis in systemic sclerosis. A study using high resolution computed tomography. Clin Exp Rheumatol 2001;19:187-90.
162. Bamji A, Cooke N. Rheumatoid arthritis and chronic bronchial suppuration. Scand J Rheumatol 1985;14:15-21.
163. Cortet B, Flipo RM, Rémy Jardin M, et al. Use of high resolution computed tomography of the lungs in patients with rheumatoid arthritis. Ann Rheum Dis 1995;54:815-19.
164. Despaux J, Manzoni P, Toussirot E, et al. Prospective study of the prevalence of bronchiectasis in rheumatoid arthritis using high-resolution computed tomography. Rev Rhum Engl Ed 1998;65:453-61.
165. Despaux J, Polio JC, Toussirot E, et al. Rheumatoid arthritis and bronchiectasis. A retrospective study of fourteen cases. Rev Rhum Engl Ed 1996;63:801-8.
166. Perez T, Remy-Jardin M, Cortet B. Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings. Am J Respir Crit Care Med 1998;157:1658-65.
167. Cortet B, Perez T, Roux N, et al. Pulmonary function tests and high resolution computed tomography of the lungs in patients with rheumatoid arthritis. Ann Rheum Dis 1997;56:596-600.
168. Tanaka N, Kim JS, Newell JD, et al. Rheumatoid arthritis-related lung diseases: CT Findings. Radiology 2004;232:81-91. (Pubitemid 38796446)
169. Cohen M, Sahn SA. Bronchiectasis in systemic diseases. Chest 1999;116:1063-74.
170. Shadick NA, Fanta CH, Weinblatt ME, et al. Bronchiectasis. A late feature of severe rheumatoid arthritis. Medicine (Baltimore) 1994;73:161-70.
171. Walker WC. Pulmonary infections and rheumatoid arthritis. Q J Med 1967;36:239-51.
172. Solanki T, Neville E. Bronchiectasis and rheumatoid disease: is there an association? Br J Rheumatol 1992;31:691-3.
173. Remy-Jardin M, Remy J, Cortet B, et al. Lung changes in rheumatoid arthritis: CT findings. Radiology 1994;193:375-82.
174. El Maghraoui A, Chaouir S, Abid A, et al. Lung findings on thoracic high-resolution computed tomography in patients with ankylosing spondylitis. Correlations with disease duration, clinical findings and pulmonary function testing. Clin Rheumatol 2004;23:123-8.
175. Al-Hajjaj MS. Bronchiectasis and mediastinal neurofibroma in a Saudi female with Ehlers-Danlos syndrome. Ann Saudi Med 2000;20:419-20.
176. Mahadeva R, Flower C, Shneerson J. Bronchiectasis in association with coeliac disease. Thorax 1998;53:527-9.
177. Camus P, Colby TV. The lung in inflammatory bowel disease. Eur Respir J 2000;15:5-10.
178. Camus P, Piard F, Ashcroft T, et al. The lung in inflammatory bowel disease. Medicine (Baltimore) 1993;72:151-83.
179. Ellerman A, Bisgaard H. Longitudinal study of lung function in a cohort of primary ciliary dyskinesia. Eur Respir J 1997;10:2376-9.
180. Chin GY, Karas DE, Kashgarian M. Correlation of presentation and pathologic condition in primary ciliary dyskinesia. Arch Otolaryngol Head Neck Surg 2002;128:1292-4.
181. Mygind N, Pedersen M. Nose-, sinus- and ear-symptoms in 27 patients with primary ciliary dyskinesia. Eur J Respir Dis Suppl 1983;127:96-101. (Pubitemid 13036870)
182. Pedersen M, Stafanger G. Bronchopulmonary symptoms in primary ciliary dyskinesia. A clinical study of 27 patients. Eur J Respir Dis Suppl 1983;127:118-28. (Pubitemid 13036872)
183. Longstreth GF, Weitzman SA, Browning RJ, et al. Bronchiectasis and homozygous alpha1-antitrypsin deficiency. Chest 1975;67:233-5.
184. Al Kassimi F. Bronchiectasis and homozygous (P1ZZ) alpha 1-antitrypsin deficiency. Thorax 1996;51:228.
185. Barker AF. Alpha-l-antitrypsin deficiency presenting as bronchiectasis. Br J Dis Chest 1986;80:97.
186. Cuvelier A, Muir JF, Hellot MF, et al. Distribution of alpha1-antitrypsin alleles in patients with bronchiectasis. Chest 2000;117:415-19.
187. King MA, Stone JA, Diaz PT, et al. Alpha 1-antitrypsin deficiency: evaluation of bronchiectasis with CT. Radiology 1996;199:137-41.
188. Varpela E, Koistinen J, Korhola O, et al. Deficiency of alpha1-antitrypsin and bronchiectasis. Ann Clin Res 1978;10:79-82.
189. Shin MS, Ho KJ. Bronchiectasis in patients with alpha 1-antitrypsin deficiency. A rare occurrence? Chest 1993;104:1384-6.
190. Jones DK, Godden D, Cavanagh P. Alpha-1-antitrypsin deficiency presenting as bronchiectasis. Br J Dis Chest 1985;79:301-4.
191. Guest PJ, Hansell DM. High resolution computed tomography (HRCT) in emphysema associated with alpha-1-antitrypsin deficiency. Clin Radiol 1992;45:260-6.
192. Scott JH, Anderson CL, Shankar PS, et al. Alpha1-antitrypsin deficiency with diffuse bronchiectasis and cirrhosis of the liver. Chest 1977;71:535-8.
193. Seersholm N, Kok-Jensen A. Clinical features and prognosis of life time nonsmokers with severe alpha 1-antitrypsin deficiency. Thorax 1998;53:265-8.
194. Brantly ML, Paul LD, Miller BH, et al. Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis 1988;138:327-36.
195. Hutchison DC, Tobin MJ, Cook PJ. Alpha 1 antitrypsin deficiency: clinical and physiological features in heterozygotes of Pi type SZ. A survey by the British Thoracic Association. Br J Dis Chest 1983;77:28-34.
196. Tobin MJ, Cook PJ, Hutchison DC. Alpha 1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association. Br J Dis Chest 1983;77:14-27.
197. Tomashefski JF Jr, Crystal RG, Wiedemann HP, et al. The bronchopulmonary pathology of alpha-1 antitrypsin (AAT) deficiency: findings of the Death Review Committee of the national registry for individuals with severe deficiency of alpha-1 antitrypsin. Hum Pathol 2004;35:1452-61.
198. Falk GA, Smith JP. Chronic bronchitis: a seldom noted manifestation of homozygous alpha 1-antitrypsin deficiency. Chest 1971;60:166-9.
199. Rodriguez-Cintron W, Guntupalli K, Fraire AE. Bronchiectasis and homozygous (P1ZZ) alpha 1-antitrypsin deficiency in a young man. Thorax 1995;50:424-5.
200. Eriksson S. Studies in alpha 1-antitrypsin deficiency. Acta Med Scand Suppl 1965;432:1-85.
201. el-Kassimi FA, Warsy AS, Uz-Zaman A, et al. Alpha 1-antitrypsin serum levels in widespread bronchiectasis. Respir Med 1989;83:119-21.
202. Parr DG, Guest PG, Reynolds JH, et al. Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency. Am J Respir Crit Care Med 2007;176:1215-21.
203. Awerbuch MS. The yellow nail syndrome, bronchiectasis and Raynaud's disease. A relationship. Med J Aust 1976;2:829-30.
204. Bowers D. Unequal breasts, yellow nails, bronchiectasis and lymphedema. Can Med Assoc J 1969;100:437-8.
205. Venencie PY, Dicken CH. Yellow nail syndrome: report of five cases. J Am Acad Dermatol 1984;10:187-91.
206. Hendry WF, A'Hern RP, Cole PJ. Was Young's syndrome caused by exposure to mercury in childhood? BMJ 1993;307:1579-82.
207. Le Lannou D, Jezequel P, Blayau M, et al. Obstructive azoospermia with agenesis of vas deferens or with bronchiectasia (Young's syndrome): a genetic approach. Humanit Rep 1995;10:338-41.
208. Neville E, Brewis R, Yeates WK, et al. Respiratory tract disease and obstructive azoospermia. Thorax 1983;38:929-33.
209. Chang AB, Gaffney JT, Eastburn MM, et al. Cough quality in children: a comparison of subjective vs. bronchoscopic findings. Respir Res 2005;6:3.
210. Davies H, Gordon I, Matthew DJ, et al. Long term follow up after inhalation of foreign bodies. Arch Dis Child 1990;65:619-21.
211. Shields MD, Bush A, Everard ML, et al. BTS guidelines: recommendations for the assessment and management of cough in children. Thorax 2008;63(Suppl 3): iii1-15.
212. Chang AB, Grimwood K, Mulholland EK, et al. Bronchiectasis in indigenous children in remote Australian communities. Med J Aust 2002;177:200-4.
213. Clark NS. Bronchiectasis in childhood. BMJ 1963;5323:80-8.
214. Coren ME, Meeks M, Morrison I, et al. Primary ciliary dyskinesia: age at diagnosis and symptom history. Acta Paediatr 2002;91:667-9.
215. Dukes RJ, Rosenow EC 3rd, Hermans PE. Pulmonary manifestations of
216. Edwards EA, Metcalfe R, Milne DG, et al. Retrospective review of children presenting with non cystic fibrosis bronchiectasis: HRCT features and clinical relationships. Pediatr Pulmonol 2003;36:87-93.
217. Lanning P, Simila S, Linna O. Late pulmonary sequelae after type 7 adenovirus pneumonia. Ann Radiol (Paris) 1980;23:132-6.
218. Redding G, Singleton R, Lewis T, et al. Early radiographic and clinical features associated with bronchiectasis in children. Pediatr Pulmonol 2004;37:297-304.
219. Patel IS, Vlahos I, Wilkinson TM, et al. Bronchiectasis, exacerbation indices and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;70:400-7.
220. Currie DC, Cooke JC, Morgan AD, et al. Interpretation of bronchograms and chest radiographs in patients with chronic sputum production. Thorax 1987;42:278-84.
221. Ellis DA, Thornley PE, Wightman AJ, et al. Present outlook in bronchiectasis: clinical and social study and review of factors influencing prognosis. Thorax 1981;36:659-64.
222. Langan CE, Platt DJ, Guthrie AJ. A study of difficult respiratory infections in general practice. Scott Med J 1982;27 Spec No:S17-20.
223. Smith IE, Jurriaans E, Diederich S, et al. Chronic sputum production: correlations between clinical features and findings on high resolution computed tomographic scanning of the chest. Thorax 1996;51:914-18.
224. Stockley RA, Bayley D, Hill SL, et al. Assessment of airway neutrophils by sputum colour: correlation with airways inflammation. Thorax 2001;56:366-72.
225. O'Brien C, Guest PJ, Hill SL, et al. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 2000;55:635-42.
226. Martinez FJ. Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007;4:647-58.
227. Field CE. Bronchiectasis. Third report on a follow-up study of medical and surgical cases from childhood. Arch Dis Child 1969;44:551-61.
228. Lee DJ, Conlan AA. Bronchiectasis in urban black children. S Afr Med J 1985;67:817-19.
229. Nakanishi M, Maekawa N, Naito M. Follow-up study of bronchiectasis. Acta Tuberc Jpn 1966;16:65-77.
230. Roberts DE, Higgs E, Cole PJ. Selective medium that distinguishes haemophilus influenzae from haemophilus parainfluenzae in clinical specimens: its value in investigating respiratory sepsis. J Clin Pathol 1987;40:75-6.
231. Edwards EA, Narang I, Li A, et al. HRCT lung abnormalities are not a surrogate for exercise limitation in bronchiectasis. Eur Respir J 2004;24:538-44.
232. Li AM, Sonnappa S, Lex C, et al. Non-CF bronchiectasis: does knowing the aetiology lead to changes in management? Eur Respir J 2005;26:8-14.
233. Wilson CB, Jones PW, O'Leary CJ, et al. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. Eur Respir J 1997;10:1754-60.
234. McGuinness G, Beacher JR, Harkin TJ, et al. Hemoptysis: prospective highresolution CT/bronchoscopic correlation. Chest 1994;105:1155-62.
235. Chan SL, Chan Yeung MM, Ooi GC, et al. Validation of the Hong Kong Chinese version of the St George Respiratory Questionnaire in patients with bronchiectasis. Chest 2002;122:2030-7.
236. Chan TH, Ho SS, Lai CK, et al. Comparison of oral ciprofloxacin and amoxycillin in treating infective exacerbations of bronchiectasis in Hong Kong. Chemotherapy 1996;42:150-6.
237. Lam WK, Chau PY, So SY, et al. Ofloxacin compared with amoxycillin in treating infective exacerbations in bronchiectasis. Respir Med 1989;83:299-303.
238. Mazzocco MC, Owens GR, Kirilloff LH, et al. Chest percussion and postural drainage in patients with bronchiectasis. Chest 1985;88:360-3.
239. Munro NC, Currie DC, Garbett ND, et al. Chest pain in chronic sputum production: a neglected symptom. Respir Med 1989;83:339-41.
240. Nath AR, Capel LH. Lung crackles in bronchiectasis. Thorax 1980;35:694-9.
241. O'Donnell C, Barker AF, Ilowite JS, et al. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. Chest 1998;113:1329-34.
242. O'Leary CJ, Wilson CB, Hansell DM, et al. Relationship between psychological well-being and lung health status in patients with bronchiectasis. Respir Med 2002;96:686-92.
243. Piirilä P, Sovijärvi AR, Kaisla T, et al. Crackles in patients with fibrosing alveolitis, bronchiectasis, COPD, and heart failure. Chest 1991;99:1076-83.
244. Rayner CF, Tillotson G, Cole PJ, et al. Efficacy and safety of long-term ciprofloxacin in the management of severe bronchiectasis. J Antimicrob Chemother 1994;34:149-56.
245. Stockley RA, Hill SL, Morrison HM, et al. Elastolytic activity of sputum and its relation to purulence and to lung function in patients with bronchiectasis. Thorax 1984;39:408-13.
246. Tsang KW, Chan WM, Ho PL, et al. A comparative study on the efficacy of levofloxacin and ceftazidime in acute exacerbation of bronchiectasis. Eur Respir J 1999;14:1206-9.
247. Tsang KW, Ho PI, Chan KN, et al. A pilot study of low-dose erythromycin in bronchiectasis. Eur Respir J 1999;13:361-4.
248. Wilson CB, Jones PW, O'Leary CJ, et al. Systemic markers of inflammation in stable bronchiectasis. Eur Respir J 1998;12:820-4.
249. Currie DC, Munro C, Gaskell D, et al. Practice, problems and compliance with postural drainage: a survey of chronic sputum producers. Br J Dis Chest 1986;80:249-53.
250. Haynes C, Jones P, O'Leary C, et al. Comparison of quality of life measures, physiological measures, and extent of disease measured by CT scan in bronchiectasis. Qual Life Res 1995;4:437-8.
251. Wilson CB, Jones PW, O'Leary CJ, et al. Validation of the St George's Respiratory Questionnaire in bronchiectasis. Am J Respir Crit Care Med 1997;156:536-41.
252. Murphy MB, Reen DJ, Fitzgerald MX. Atopy, immunological changes, and respiratory function in bronchiectasis. Thorax 1984;39:179-84.
253. Phelan PD, Landau LI, Williams HE. Lung disease associated with infantile agammaglobulinaemia. Aust Paediatr J 1973;9:147-51.
254. Rodrigo MJ, Vendrell M, Cruz MJ, et al. Utility of the antibody response to a conjugated Haemophilus influenzae type B vaccine for diagnosis of primary humoral immunodeficiency. Am J Respir Crit Care Med 2000;162:1462-5.
255. Stanley PJ, Corbo G, Cole PJ. Serum IgG subclasses in chronic and recurrent respiratory infections. Clin Exp Immunol 1984;58:703-8.
256. Ambrosino DM, Siber GR, Chilmonczyk BA, et al. An immunodeficiency characterized by impaired antibody responses to polysaccharides. N Engl J Med 1987;316:790-3.
257. Noroski LM, Shearer WT. Screening for primary immunodeficiencies in the clinical immunology laboratory. Clin Immunol Immunopathol 1998;86:237-45.
258. Folds JD, Schmitz JL. 24. Clinical and laboratory assessment of immunity. J Allergy Clin Immunol 2003;111(2 Suppl):S702-11.
259. Shearer WT, Buckley RH, Engler RJ, et al. Practice parameters for the diagnosis and management of immunodeficiency. The Clinical and Laboratory Immunology Committee of the American Academy of Allergy, Asthma, and Immunology (CLIC-AAAAI). Ann Allergy Asthma Immunol 1996;76:282-94.
260. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999;93:190-7.
261. Burke CM, Theodore J, Dawkins KD, et al. Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. Chest 1984;86:824-9.
262. Danner I, Boisseau P, Chailleux E, et al. Respiratory epithelial ion transport in patients with disseminated bronchiectasis. Eur Respir J 1999;13:1276-80.
263. Shah PL, Mawdsley S, Nash K, et al. Determinants of chronic infection with Staphylococcus aureus in patients with bronchiectasis. Eur Respir J 1999; 14:1340-4.
264. Davis PB, Del Rio S, Muntz JA, et al. Sweat chloride concentration in adults with pulmonary diseases. Am Rev Respir Dis 1983;128:34-7.
265. Baumer JH. Evidence based guidelines for the performance of the sweat test for the investigation of cystic fibrosis in the UK. Arch Dis Child 2003; 88:1126-7.
266. Gilljam M, Bjorck E. Cystic fibrosis diagnosed in an elderly man. Respiration 2004;71:98-100.
267. Anon. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005;171:912-30.
268. Angrill J, Agustí C, De Celis R, et al. Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. Am J Respir Crit Care Med 2001;164:1628-32.
269. Pang JA, Cheng A, Chan HS, et al. The bacteriology of bronchiectasis in Hong Kong investigated by protected catheter brush and bronchoalveolar lavage. Am Rev Respir Dis 1989;139:14-17.
270. Cabello H, Torres A, Celis R, et al. Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study. Eur Respir J 1997;10:1137-44. (Pubitemid 27201822)
271. Fernald GW. Bronchiectasis in childhood: a 10-year survey of cases treated at North Carolina Memorial Hospital. N C Med J 1978;39:368-72.
272. Gardiner IT, Blenkharn I, Stradling P, et al. Anaerobic bacteriology of chronic bronchial disease, with a refined method of sampling bronchial secretions. Br J Dis Chest 1977;71:277-84.
273. Moore EH. Atypical mycobacterial infection in the lung: CT appearance. Radiology 1993;187:777-82.
274. Tanaka E, Amitani R, Niimi A, et al. Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 1997;155:2041-6. (Pubitemid 27256136)
275. Steinfort CL, Todd H, Higgs E, et al. Bacteriology of daily purulent sputum production. Thorax 1986;42:235.
276. Chang AB, Boyce NC, Masters IB, et al. Bronchoscopic findings in children with non-cystic fibrosis chronic suppurative lung disease. Thorax 2002;57:935-8.
277. van der Bruggen Bogaarts BA, van der Bruggen HM, van Waes PF, et al. Screening for bronchiectasis. A comparative study between chest radiography and high-resolution CT. Chest 1996;109:608-11.
278. Woodring JH. Improved plain film criteria for the diagnosis of bronchiectasis. J Ky Med Assoc 1994;92:8-13.
279. Fink C, Hallscheidt PJ, Noeldge G, et al. Clinical comparative study with a largearea amorphous silicon flat-panel detector: image quality and visibility of anatomic structures on chest radiography. AJR Am J Roentgenol 2002;178:481-6.
280. Coblentz CL, Babcook CJ, Alton D, et al. Observer variation in detecting the radiologic features associated with bronchiolitis. Invest Radiol 1991;26:115-18.
281. Greene KE, Takasugi JE, Godwin JD, et al. Radiographic changes in acute exacerbations of cystic fibrosis in adults: a pilot study. AJR Am J Roentgenol 1994;163:557-62.
282. Grenier P, Maurice F, Musset D, et al. Bronchiectasis: assessment by thin-section CT. Radiology 1986;161:95-9.
283. Munro NC, Cooke JC, Currie DC, et al. Comparison of thin section computed tomography with bronchography for identifying bronchiectatic segments in patients with chronic sputum production. Thorax 1990;45:135-9.
284. Roberts HR, Wells AU, Milne DG, et al. Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests. Thorax 2000;55:198-204.
285. Hansell DM. Bronchiectasis. Radiol Clin North Am 1998;36:107-28.
286. Matsuoka S, Uchiyama K, Shima H, et al. Bronchoarterial ratio and bronchial wall thickness on high-resolution CT in asymptomatic subjects: correlation with age and smoking. AJR Am J Roentgenol 2003;180:513-18.
287. Vikgren J, Boijsen M, Andelid K, et al. High-resolution computed tomography in healthy smokers and never-smokers: a 6-year follow-up study of men born in 1933. Acta Radiol 2004;45:44-52.
288. Ketai L, Coutsias C, Williamson S, et al. Thin-section CT evidence of bronchial thickening in children with stable asthma: bronchoconstriction or airway remodeling? Acad Radiol 2001;8:257-64.
289. Lucaya J, Piqueras J, Garcia-Pena P, et al. Low-dose high-resolution CT of the chest in children and young adults: dose, cooperation, artifact incidence, and image quality. AJR Am J Roentgenol 2000;175:985-92.
290. Desai SR, Wells AU, Cheah FK, et al. The reproducibility of bronchial circumference measurements using computed tomography. Br J Radiol 1994;67:257-62.
291. Engeler CE, Tashjian JH, Engeler CM, et al. Volumetric high-resolution CT in the diagnosis of interstitial lung disease and bronchiectasis: diagnostic accuracy and radiation dose. AJR Am J Roentgenol 1994;163:31-5.
292. Hansell DM, Wells AU, Rubens MB, et al. Bronchiectasis: functional significance of areas of decreased attenuation at expiratory CT. Radiology 1994;193:369-74.
293. Jung KJ, Lee KS, Kim SY, et al. Low-dose, volumetric helical CT: image quality, radiation dose, and usefulness for evaluation of bronchiectasis. Invest Radiol 2000;35:557-63.
294. Kim JS, Müller NL, Park CS, et al. Cylindrical bronchiectasis: diagnostic findings on thin-section CT. AJR Am J Roentgenol 1997;168:751-4.
295. Lucidarme O, Grenier P, Coche E, et al. Bronchiectasis: comparative assessment with thin-section CT and helical CT. Radiology 1996;200:673-9.
296. Marti Bonmati L, Catala FJ, Ruiz Perales F. Computed tomography differentiation between cystic bronchiectasis and bullae. J Thorac Imaging 1991;7:83-5.
297. Remy Jardin M, Amara A, Campistron P, et al. Diagnosis of bronchiectasis with multislice spiral CT: accuracy of 3-mm-thick structured sections. Eur Radiol 2003;13:1165-71.
298. Sung Yon M, Lee Kyung S, Yi Chin A, et al. Additional coronal images using low-milliamperage multidetector-row computed tomography: effectiveness in the diagnosis of bronchiectasis. J Comput Assist Tomogr 2003;27:490-5.
299. Yi Chin A, Lee Kyung S, Kim Tae S, et al. Multidetector CT of bronchiectasis: effect of radiation dose on image quality. AJR Am J Roentgenol 2003;181:501-5.
300. Hoppe H, Walder B, Sonnenschein M, et al. Multidetector CT virtual bronchoscopy to grade tracheobronchial stenosis. AJR Am J Roentgenol 2002;178:1195-200.
301. Simon M, Boiselle PM, Choi JR, et al. Paddle-wheel CT display of pulmonary arteries and other lung structures: a new imaging approach. AJR Am J Roentgenol 2001;177:195-8.
302. Kelly DM, Hasegawa I, Borders R, et al. High-resolution CT using MDCT: comparison of degree of motion artifact between volumetric and axial methods. AJR Am J Roentgenol 2004;182:757-9.
303. Schoepf UJ, Becker CR, Bruening RD, et al. Electrocardiographically gated thinsection CT of the lung. Radiology 1999;212:649-54.
304. Garcia-Pena P, Lucaya J. HRCT in children: technique and indications. Eur Radiol 2004;14(Suppl) 4:L13-30.
305. Lee EY, Siegel MJ, Hildebolt CF, et al. MDCT evaluation of thoracic aortic anomalies in pediatric patients and young adults: comparison of axial, multiplanar, and 3D images. AJR Am J Roentgenol 2004;182:777-84.
306. Cody DD, Moxley DM, Krugh KT, et al. Strategies for formulating appropriate MDCT techniques when imaging the chest, abdomen, and pelvis in pediatric patients. AJR Am J Roentgenol 2004;182:849-59.
307. Worthy SA, Brown MJ, Muller NL. Technical report: Cystic air spaces in the lung: change in size on expiratory high-resolution CT in 23 patients. Clin Radiol 1998;53:515-19.
308. Kang EY, Miller RR, Muller NL. Bronchiectasis: comparison of preoperative thinsection CT and pathologic findings in resected specimens. Radiology 1995;195:649-54.
309. Bankier AA, Fleischmann D, Mallek R, et al. Bronchial wall thickness: appropriate window settings for thin-section CT and radiologic-anatomic correlation. Radiology 1996;199:831-6.
310. Grenier P, Cordeau MP, Beigelman C. High-resolution computed tomography of the airways. J Thorac Imaging 1993;8:213-29.
311. Diederich S, Jurriaans E, Flower CD. Interobserver variation in the diagnosis of bronchiectasis on high- resolution computed tomography. Eur Radiol 1996;6:801-6.
312. Reiff DB, Wells AU, Carr DH, et al. CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types. Am J Roentgenol 1995;165:261-7.
313. Naidich DP, McCauley DI, Khouri NF, et al. Computed tomography of bronchiectasis. J Comput Assist Tomogr 1982;6:437-44.
314. Kim JS, Muller NL, Park CS, et al. Bronchoarterial ratio on thin section CT: comparison between high altitude and sea level. J Comput Assist Tomogr 1997;21:306-11.
315. Remy-Jardin M, Remy J, Boulenguez C, et al. Morphologic effects of cigarette smoking on airways and pulmonary parenchyma in healthy adult volunteers: CT evaluation and correlation with pulmonary function tests. Radiology 1993;186:107-15.
316. Gruden JF, Webb WR. Identification and evaluation of centrilobular opacities on high-resolution CT. Semin Ultrasound CT MR 1995;16:435-49.
317. Collins J, Blankenbaker D, Stern EJ. CT patterns of bronchiolar disease: what is "tree-in-bud"? AJR Am J Roentgenol 1998;171:365-70.
318. Franquet T, Stern EJ. Bronchiolar inflammatory diseases: high-resolution CT findings with histologic correlation. Eur Radiol 1999;9:1290-303.
319. Cartier Y, Kavanagh PV, Johkoh T, et al. Bronchiectasis: accuracy of high-resolution CT in the differentiation of specific diseases. Am J Roentgenol 1999;173:47-52.
320. Curtin JJ, Webster AD, Farrant J, et al. Bronchiectasis in hypogammaglobulinaemiaea computed tomography assessment. Clin Radiol 1991;44:82-4.
321. Lee PH, Carr DH, Rubens MB, et al. Accuracy of CT in predicting the cause of bronchiectasis. Clin Radiol 1995;50:839-41.
322. Lynch DA, Simone PM, Fox MA, et al. CT features of pulmonary Mycobacterium avium complex infection. J Comput Assist Tomogr 1995;19:353-60.
323. Swensen SJ, Hartman TE, Williams DE. Computed tomographic diagnosis of Mycobacterium avium-intracellulare complex in patients with bronchiectasis. Chest 1994;105:49-52.
324. Cole P, Flower C, Lavender JP. Clinical and imaging aspects of bronchiectasis. In: Potchen EJ, Grainger RG, Greene R, eds. Pulmonary radiology: the Fleischner Society. Philadelphia: WB Saunders, 1993:242-58.
325. Ward S, Heyneman L, Lee MJ, et al. Accuracy of CT in the diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients. AJR Am J Roentgenol 1999;173:937-42.
326. Nadel HR, Stringer DA, Levison H, et al. The immotile cilia syndrome: radiological manifestations. Radiology 1985;154:651-5.
327. Hansell DM, Strickland B. High-resolution computed tomography in pulmonary cystic fibrosis. Br J Radiol 1989;62:1-5.
328. Gurney JW, Habbe TG, Hicklin J. Distribution of disease in cystic fibrosis: correlation with pulmonary function. Chest 1997;112:357-62.
329. Woodring JH, Howard RS 2nd, Rehm SR. Congenital tracheobronchomegaly (Mounier-Kuhn syndrome): a report of 10 cases and review of the literature. J Thorac Imaging 1991;6:1-10.
330. Loubeyre P, Paret M, Revel D, et al. Thin-section CT detection of emphysema associated with bronchiectasis and correlation with pulmonary function tests. Chest 1996;109:360-5. (Pubitemid 26058589)
331. Lynch DA, Newell J, Hale V, et al. Correlation of CT findings with clinical evaluations in 261 patients with symptomatic bronchiectasis. AJR Am J Roentgenol 1999;173:53-8.
332. Bhalla M, Turcios N, Aponte V, et al. Cystic fibrosis: scoring system with thinsection CT. Radiology 1991;179:783-8.
333. Sheehan RE, Wells AU, Copley SJ, et al. A comparison of serial computed tomography and functional change in bronchiectasis. Eur Respir J 2002; 20:581-7.
334. Helbich TH, Heinz-Peer G, Fleischmann D, et al. Evolution of CT findings in patients with cystic fibrosis. AJR Am J Roentgenol 1999;173:81-8.
335. Shah RM, Sexauer W, Ostrum BJ, et al. High-resolution CT in the acute exacerbation of cystic fibrosis: evaluation of acute findings, reversibility of those findings, and clinical correlation. AJR Am J Roentgenol 1997; 169:375-80.
336. Maffessanti M, Candusso M, Brizzi F, et al. Cystic fibrosis in children: HRCT findings and distribution of disease. J Thorac Imaging 1996;11:27-38.
337. Nathanson I, Conboy K, Murphy S, et al. Ultrafast computerized tomography of the chest in cystic fibrosis: a new scoring system. Pediatr Pulmonol 1991;11:81-6.
338. Santamaria F, Grillo G, Guidi G, et al. Cystic fibrosis: when should high-resolution computed tomography of the chest be obtained? Pediatrics 1998;101:908-13.
339. Helbich TH, Heinz-Peer G, Eichler I, et al. Cystic fibrosis: CT assessment of lung involvement in children and adults. Radiology 1999;213:537-44.
340. Brody AS, Molina PL, Klein JS, et al. High-resolution computed tomography of the chest in children with cystic fibrosis: support for use as an outcome surrogate. Pediatr Radiol 1999;29:731-5.
341. de Jong PA, Ottink MD, Robben SG, et al. Pulmonary disease assessment in cystic fibrosis: comparison of CT scoring systems and value of bronchial and arterial dimension measurements. Radiology 2004;231:434-9.
342. Angrill J, Agustí C, de Celis R, et al. Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax 2002;57:15-19.
343. Chan CH, Ho AK, Chan RC, et al. Mycobacteria as a cause of infective exacerbation in bronchiectasis. Postgrad Med J 1992;68:896-9.
344. Evans SA, Turner SM, Bosch BJ, et al. Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa. Eur Respir J 1996;9:1601-4.
345. Bilton D, Pye A, Johnson MM, et al. The isolation and characterization of nontypeable Haemophilus influenzae from the sputum of adult cystic fibrosis patients. Eur Respir J 1995;8:948-53.
346. Health Protection Agency. National Standard Operating Procedures e Bacteriology. Health Protection Agency, 2003.
347. Koh YY, Lee MH, Sun YH, et al. Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study. Eur Respir J 1997;10:994-9.
348. Landau LI, Phelan PD, Williams HE. Ventilatory mechanics in patients with bronchiectasis starting in childhood. Thorax 1974;29:304-12.
349. Bahous J, Cartier A, Pineau L, et al. Bronchiectasis, congenital and acquired Pulmonary function tests and airway responsiveness to methacholine in chronic bronchiectasis of the adult. BMJ 1979;1:1380.
350. Bahous J, Cartier A, Pineau L, et al. Pulmonary function tests and airway responsiveness to methacholine in chronic bronchiectasis of the adult. Bull Eur Physiopathol Respir 1984;20:375-80.
351. Cherniack NS, Carton RW. Factors associated with respiratory insufficiency in bronchiectasis. Am J Med 1966;41:562-71.
352. Hassan JA, Saadiah S, Roslan H, et al. Bronchodilator response to inhaled beta-2 agonist and anticholinergic drugs in patients with bronchiectasis. Respirology 1999;4:423-6.
353. Hill SL, Stockley RA. Effect of short and long term antibiotic response on lung function in bronchiectasis. Thorax 1986;41:798-800.
354. Ip M, Lam WK, So SY, et al. Analysis of factors associated with bronchial hyperreactivity to methacholine in bronchiectasis. Lung 1991;169:43-51.
355. Koulouris NG, Retsou S, Kosmas E, et al. Tidal expiratory flow limitation, dyspnoea and exercise capacity in patients with bilateral bronchiectasis. Eur Respir J 2003;21:743-8.
356. Nogrady SG, Evans WV, Davies BH. Reversibility of airways obstruction in bronchiectasis. Thorax 1978;33:635-7.
357. Pande JN, Jain BP, Gupta RG, et al. Pulmonary ventilation and gas exchange in bronchiectasis. Thorax 1971;26:727-33.
358. Pang J, Chan HS, Sung JY. Prevalence of asthma, atopy, and bronchial hyperreactivity in bronchiectasis: a controlled study. Thorax 1989;44:948-51.
359. Cherniack N, Vosti KL, Saxton GA, et al. Pulmonary function tests in fifty patients with bronchiectasis. J Lab Clin Med 1959;53:693-707.
360. Bjorkander J, Bake B, Hanson LA. Primary hypogammaglobulinaemia: impaired lung function and body growth with delayed diagnosis and inadequate treatment. Eur J Respir Dis 1984;65:529-36.
361. Bjorkander J, Bake B, Hanson LA. Bronchitis in patients with hypogammaglobulinemia and other immunodeficiencies. Eur J Respir Dis Suppl 1982;118:97-9.
362. Bass H, Whitcomb JF, Forman R. Exercise training: therapy for patients with chronic obstructive pulmonary disease. Chest 1970;57:116-21.
363. Hung TC, Lin HC, Lin KJ, et al. 133Xenon ventilation scan as a functional assessment in bronchiectasis. Changgeng Yi Xue Za Zhi 1998;21:403-8.
364. Swaminathan S, Kuppurao KV, Somu N, et al. Reduced exercise capacity in noncystic fibrosis bronchiectasis. Indian J Pediatr 2003;70:553-6.
365. Newall C, Henson M, McConnell AK, et al. The effect of inspiratory muscle training (IMT) on pulmonary function, exercise tolerance and quality of life in patients with bronchiectasis (BE). Eur Respir J 2000;16(Suppl 31):36s.
366. Newall C, Henson M, McConnell AK, et al. The effects of pulmonary rehabilitation (PR) in patients with bronchiectasis (BE). Eur Respir J 2000;16(Suppl 31):330s.
367. Hill SL, Burnett D, Hewetson KA, et al. The response of patients with purulent bronchiectasis to antibiotics for four months. Q J Med 1988;66:163-73.
368. Hill SL, Morrison HM, Burnett D, et al. Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalation. Thorax 1986;41:559-65.
369. Tageldin MA, Palmer LB, El Tayeb MN, et al. Nebulizer therapy with antibiotics in chronic suppurative lung disease. J Aerosol Med 1994;7:345-50.
370. Young Whan K, Yeon Mok O, Man Pyo J, et al. The effect of low-dose longterm erythromycin on bronchiectasis. Tuberc Respir Dis 1993;40:390-4.
371. Fox RE, Dowling HF, Saxton GA Jr. Treatment of bronchiectasis and chronic bronchitis with intravenous tetracycline. Antibiot Annu 1956:349-54.
372. Cherniack NS, Dowling HF, Carton RW, et al. The role of acute lower respiratory infection in causing pulmonary insufficiency in bronchiectasis. Ann Intern Med 1967;66:489-97.
373. Keistinen T, Säynäjäkangas O, Tuuponen T, et al. Bronchiectasis: an orphan disease with a poorly-understood prognosis. Eur Respir J 1997;10:2784-7.
374. Cherniack NS, Vosti KL, Dowling HF, et al. Long-term treatment of bronchiectasis and chronic bronchitis; a controlled study of the effects of tetracycline, penicillin, and an oleandomycinpenicillin mixture. AMA Arch Intern Med 1959;103:345-53.
375. King PT, Holdsworth SR, Freezer NJ, et al. Outcome in adult bronchiectasis. COPD 2005;2:27-34.
376. Mahadeva R, Webb K, Westerbeek RC, et al. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ 1998;316:1771-5.
377. French J, Bilton D, Campbell F. Nurse specialist care for bronchiectasis. Cochrane Database Syst Rev 2003(3):CD004319.
378. Patterson JE, Bradley JM, Elborn JS. Airway clearance in bronchiectasis: a randomized crossover trial of active cycle of breathing techniques (incorporating postural drainage and vibration) versus test of incremental respiratory endurance. Chron Respir Dis 2004;1:127-30.
379. Thompson CS, Harrison S, Ashley J, et al. Randomised crossover study of the Flutter device and the active cycle of breathing technique in non-cystic fibrosis bronchiectasis. Thorax 2002;57:446-8.
380. Eaton T, Young P, Zeng I, et al. A randomized evaluation of the acute efficacy, acceptability and tolerability of flutter and active cycle of breathing with and without postural drainage in non-cystic fibrosis bronchiectasis. Chron Respir Dis 2007;4:23-30.
381. Tsang SM, Jones AY. Postural drainage or Flutter(R) device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiother J 2003;21:29-36.
382. Patterson JE, Bradley JM, Hewitt O, et al. Airway clearance in bronchiectasis: a randomized crossover trial of active cycle of breathing techniques versus Acapella. Respiration 2005;72:239-42.
383. Cecins NM, Jenkins SC, Pengelley J, et al. The active cycle of breathing techniqueseto tip or not to tip? Respir Med 1999;93:660-5.
384. O'Neill B, Bradley JM, McArdle N, et al. The current physiotherapy management of patients with bronchiectasis: a UK survey. Int J Clin Pract 2002;56:34-5.
385. Sutton PP, Gemmell HG, Innes N, et al. Use of nebulised saline and nebulised terbutaline as an adjunct to chest physiotherapy. Thorax 1988;43:57-60.
386. Pryor JA, Webber BA, Bethune D, et al. Physiotherapy techniques. In: Pryor JA, Prasad SA, eds. Physiotherapy for respiratory and cardiac problems. London: Churchill Livingstone, 2002:161-242.
387. Nakamura S, Mikami M, Kawakami M, et al. Comparative evaluation of the Flutter and Cornet in improving the cohesiveness of sputum from patients with bronchiectasis. Eur Respir J 1998;12(Suppl 28):212-13S.
388. Schoni MH. Autogenic drainage: a modern approach to physiotherapy in cystic fibrosis. J R Soc Med 1989;82(Suppl 16):32-7.
389. Piper AJ, Parker S, Torzillo PJ, et al. Nocturnal nasal IPPV stabilizes patients with cystic fibrosis and hypercapnic respiratory failure. Chest 1992;102:846-50.
390. Kellett F, Redfern J, Niven RM. Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis. Respir Med 2005;99:27-31.
391. Suri R, Wallis C, Bush A. Tolerability of nebulised hypertonic saline in children with cystic fibrosis. Pediatr Pulmonol 2000;30(Suppl 20):446-8.
392. Conway JH, Fleming JS, Perring S, et al. Humidification as an adjunct to chest physiotherapy in aiding tracheo-bronchial clearance in patients with bronchiectasis. Respir Med 1992;86:109-14.
393. Wills P, Greenstone M. Inhaled hyperosmolar agents for bronchiectasis. Cochrane Database Syst Rev 2002(1):CD002996.
394. Sukumalchantra Y, Park SS, Williams MH Jr. The effect of intermittent positive pressure breathing (IPPB) in acute ventilatory failure. Am Rev Respir Dis 1965;92:885-93.
395. Ayres SM, Kozam RL, Lukas DS. The effects of intermittent positive pressure breathing on intrathoracic pressure, pulmonary mechanics, and the work of breathing. Am Rev Respir Dis 1963;87:370-9.
396. Dodd ME, Webb AK. Bronchiectasis, primary ciliary dyskinesia and cystic fibrosis. In: Pryor JA, Prasad SA, eds. Physiotherapy for respiratory and cardiac problems. London: Churchill Livingstone, 2002:581-617.
397. Bradley J, Moran F, Greenstone M. Physical training for bronchiectasis. Cochrane Database Syst Rev 2002(3):CD002166.
398. Newall C, Stockley RA, Hill SL. Exercise training and inspiratory muscle training in patients with bronchiectasis. Thorax 2005;60:943-8.
399. Wills PJ, Wodehouse T, Corkery K, et al. Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in vitro sputum transportability. Am J Respir Crit Care Med 1996;154:413-17.
400. Anderson J, Eiser NM, Mills JG. Effect of H1- and H2-receptor antagonists on sputum volume and lung function in patients with generalized bronchiectasis. Br J Dis Chest 1985;79:272-4.
401. Crockett AJ, Cranston JM, Latimer KM, et al. Mucolytics for bronchiectasis. Cochrane Database Syst Rev 2001(1):CD001289.
402. Currie DC, Pavia D, Agnew JE, et al. Impaired tracheobronchial clearance in bronchiectasis. Thorax 1987;42:126-30.
403. Daviskas E, Anderson SD, Eberl S, et al. Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis. Am J Respir Crit Care Med 1999;159:1843-8.
404. Daviskas E, Anderson SD, Eberl S, et al. The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis. Chest 2001;119:414-21.
405. Desai M, Weller PH, Spencer DA. Clinical benefit from nebulized human recombinant DNase in Kartagener's syndrome. Pediatr Pulmonol 1995;20:307-8.
406. Isawa T, Teshima T, Hirano T, et al. Mucociliary clearance and transport in bronchiectasis: global and regional assessment. J Nucl Med 1990;31:543-8.
407. Olivieri D, Ciaccia A, Marangio E, et al. Role of bromhexine in exacerbations of bronchiectasis. Double-blind randomized multicenter study versus placebo. Respiration 1991;58:117-21.
408. Rutland J, Marriott C, Cole PJ. A study of the activity of mucodyne in bronchiectasis. Forum Series. London: Royal Society of Medicine, 1982;5:11-16.
409. Shibuya Y, Wills PJ, Cole PJ. The effect of erythromycin on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum. Respiration 2001;68:615-19.
410. Tamaoki J, Chiyotani A, Kobayashi K, et al. Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis. Am Rev Respir Dis 1992;145:548-25.
411. Sahay JN, Chatterjee SS, Ingram DF. The effect of methyl cysteine (visclear) in respiratory diseases. Clin Trials J 1982;19:137-43.
412. Ratjen F. Dornase in non-CF. Pediatr Pulmonol Suppl 2004;26:154-5.
413. Abu Hassan J, Saadiah S, Roslan H, et al. Bronchodilator response to inhaled beta- 2 agonist and anticholinergic drugs in patients with bronchiectasis. Respirology 1999;4:423-6.
414. Franco F, Sheikh A, Greenstone M. Short acting beta-2 agonists for bronchiectasis. Cochrane Database Syst Rev 2003(3):CD003572.
415. Lasserson T, Holt K, Evans D, et al. Anticholinergic therapy for bronchiectasis. Cochrane Database Syst Rev 2001(4):CD002163.
416. Sheikh A, Nolan D, Greenstone M. Long-acting beta-2-agonists for bronchiectasis. Cochrane Database Syst Rev 2001(4):CD002155.
417. Steele K, Greenstone M, Lasserson JA. Oral methyl-xanthines for bronchiectasis. Cochrane Database Syst Rev 2001(1):CD002734.
418. Tsang KW, Tan KC, Ho PL, et al. Inhaled fluticasone in bronchiectasis: a 12 month study. Thorax 2005;60:239-43.
419. Elborn JS, Johnston B, Allen F, et al. Inhaled steroids in patients with bronchiectasis. Respir Med 1992;86:121-4.
420. Martinez-Garcia MA, Perpina-Tordera M, Roman-Sanchez P, et al. Inhaled steroids improve quality of life in patients with steady-state bronchiectasis. Respir Med 2006;100:1623-32.
421. Tsang KW, Ho PL, Lam WK, et al. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. Am J Respir Crit Care Med 1998;158:723-7.
422. Ip M, So SY, Lam WK, et al. Nedocromil sodium in the management of chronic bronchial infection. J Clin Pharm Ther 1993;18:337-41.
423. Llewellyn Jones CG, Johnson MM, Mitchell JL, et al. In vivo study of indomethacin in bronchiectasis: effect on neutrophil function and lung secretion. Eur Respir J 1995;8:1479-87.
424. Douglas AC, Somner AR, Marks BL, et al. Effect of antibiotics on purulent sputum in chronic bronchitis and bronchiectasis. Lancet 1957;273:214-18.
425. Lam WK, Chau PY, So SY, et al. A double-blind randomized study comparing ofloxacin and amoxicillin in treating infective episodes in bronchiectasis. Infection 1986;14(Suppl 4):S290-2.
426. Pines A, Raafat H, Plucinski K, et al. Cephaloridine compared with penicillin and streptomycin in chronic purulent bronchitis. Controlled trials of increasing dosage of cephaloridine. Br J Dis Chest 1967;61:101-10.
427. Pines A, Raafat H, Siddiqui GM, et al. Treatment of severe pseudomonas infections of the bronchi. BMJ 1970;1:663-5.
428. Davies BI, Maesen FP, van Noord JA. Treatment of chronic and recurrent respiratory infections with intramuscular ceftazidime. J Antimicrob Chemother 1983;12(Suppl A):1-8.
429. Ip M, Shum D, Lauder I, et al. Effect of antibiotics on sputum inflammatory contents in acute exacerbations of bronchiectasis. Respir Med 1993;87:449-54.
430. Pines A, Khaja G, Raafat H, et al. Preliminary clinical experience with ticarcillin (BRL 2288) in 101 patients treated for severe respiratory infections. Chemotherapy 1974;20:39-44.
431. Darley ES, Bowker KE, Lovering AM, et al. Use of meropenem 3 g once daily for outpatient treatment of infective exacerbations of bronchiectasis. J Antimicrob Chemother 2000;45:247-50.
432. Bilton D, Henig N, Morrissey B, et al. Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. Chest 2006;130:1503-10.
433. Deshpande A, Pant C, Jain A, et al. Do fluoroquinolones predispose patients to Clostridium difficile associated disease? A review of the evidence. Curr Med Res Opin 2008;24:329-33.
434. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005;353:2442-9.
435. Gold R, Overmeyer A, Knie B, et al. Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis. Pediatr Infect Dis 1985;4:172-7.
436. Smith AL, Doershuk C, Goldmann D, et al. Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis. J Pediatr 1999;134:413-21.
437. Elphick HE, Tan A. Single versus combination intravenous antibiotic therapy for people with cystic fibrosis. Cochrane Database Syst Rev 2001(1):CD002007.
438. British Thoracic Society Research Committee. Ceftazidime compared with gentamicin and carbenicillin in patients with cystic fibrosis, pulmonary pseudomonas infection, and an exacerbation of respiratory symptoms. Thorax 1985;40:358-63.
439. Doring G, Conway SP, Heijerman HG, et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 2000;16:749-67.
440. Medical Research Council. Prolonged antibiotic treatment of severe bronchiectasis; a report by a subcommittee of the Antibiotics Clinical Trials (non-tuberculous) Committee of the Medical Research Council. BMJ 1957; 2:255-9.
441. Dowling HF, Mellody M, Lepper MH, et al. Bacteriologic studies of the sputum in patients with chronic bronchitis and bronchiectasis. Results of continuous therapy with tetracycline, penicillin, or an oleandomycin-penicillin mixture. Am Rev Respir Dis 1960;81:329-39.
442. Sobel S, Lichter EA, Davis JC 3rd, et al. Adverse reactions to tetracycline, penicillin and an oleandomycin-penicillin mixture used in the long-term therapy of chronic pulmonary disease. Am J Med Sci 1962;243:341-53.
443. Currie DC, Garbett ND, Chan KL, et al. Double-blind randomized study of prolonged higher-dose oral amoxycillin in purulent bronchiectasis. Q J Med 1990;76:799-816.
444. Stockley RA, Hill SL, Morrison HM. Effect of antibiotic treatment on sputum elastase in bronchiectatic outpatients in a stable clinical state. Thorax 1984;39:414-19.
445. Cymbala AA, Edmonds LC, Bauer MA, et al. The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis. Treat Respir Med 2005;4:117-22.
446. Davies G, Wilson R. Prophylactic antibiotic treatment of bronchiectasis with azithromycin. Thorax 2004;59:540-1.
447. Orriols R, Roig J, Ferrer J, et al. Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa. Respir Med 1999;93:476-80.
448. Drobnic ME, Sune P, Montoro JB, et al. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa. Ann Pharmacother 2005;39:39-44.
449. Lin HC, Cheng HF, Wang CH, et al. Inhaled gentamicin reduces airway neutrophil activity and mucus secretion in bronchiectasis. Am J Respir Crit Care Med 1997;155:2024-9.
450. Barker AF, Couch L, Fiel SB, et al. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Am J Respir Crit Care Med 2000;162:481-5.
451. Stockley RA, Hill SL, Burnett D. Nebulized amoxicillin in chronic purulent bronchiectasis. Clin Ther 1985;7:593-9.
452. Scheinberg P, Shore E. A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis. Chest 2005;127:1420-6.
453. Steinfort DP, Steinfort C. Effect of long-term nebulized colistin on lung function and quality of life in patients with chronic bronchial sepsis. Intern Med J 2007;37:495-8.
454. Morrissey BM, Harper RW. Bronchiectasis: sex and gender considerations. Clin Chest Med 2004;25:361-72.
455. Kaplan SL. Review of antibiotic resistance, antibitiotic treatment and prevention of pneumococcal pneumonia. Paediatr Respir Rev 2004;5(Suppl A):S153-8.
456. Mazier̀es J, Murris M, Didier A, et al. Limited operation for severe multisegmental bilateral bronchiectasis. Ann Thorac Surg 2003;75:382-7.
457. Remy Jardin M, Remy J, Artaud D, et al. Volume rendering of the tracheobronchial tree: Clinical evaluation of bronchographic images. Radiology 1998;208:761-70.
458. Ripe E. Bronchiectasis. I. A follow-up study after surgical treatment. Scand J Respir Dis 1971;52:96-112.
459. Ripe E. Late results after surgical treatment of bronchiectasis. Bronches 1971;21:240-57.
460. Sanderson JM, Kennedy MC, Johnson MF, et al. Bronchiectasis: results of surgical and conservative management. A review of 393 cases. Thorax 1974;29:407-16.
461. Wilson JF, Decker AM. The surgical management of childhood bronchiectasis. A review of 96 consecutive pulmonary resections in children with nontuberculous bronchiectasis. Ann Surg 1982;195:354-63.
462. Zamir O, Lernau OZ, Springer C, et al. Lung resection for bronchiectasis in children. Zeitschr Kinderchirurg 1987;42:282-5.
463. Schneiter D, Meyer N, Lardinois D, et al. Surgery for non-localized bronchiectasis. Br J Surg 2005;92:836-9.
464. Balkanli K, Genc O, Dakak M, et al. Surgical management of bronchiectasis: analysis and short-term results in 238 patients. Eur J Cardiothorac Surg 2003;24:699-702.
465. Kutlay H, Cangir AK, Enon S, et al. Surgical treatment in bronchiectasis: analysis of 166 patients. Eur J Cardiothorac Surg 2002;21:634-7.
466. Petrov D, Stanoev V, Plochev M, et al. [Indications for the surgical treatment in bronchiectasis and postoperative results]. Khirurgiia (Sofiia) 2004;60:15-18.
467. Prieto D, Bernardo J, Matos MJ, et al. Surgery for bronchiectasis. Eur J Cardiothorac Surg 2001;20:19-23; discussion 23-4.
468. Meléndez Torres JR, Padua y Gabriel A, Velasco Rodriguez VM, et al. Survival after bronchial artery embolization in massive hemoptysis: experience in 24 cases. J Bronchol 2003;10:17-21.
469. Rabkin JE, Astafjev YI, Gothman LN, et al. Transcatheter embolization in the management of pulmonary hemorrhage. Radiology 1987;163:361-5.
470. Sharma S, Kothari SS, Bhargava AD, et al. Transcatheter indigeneous coil embolization in recurrent massive hemoptysis secondary to post-tubercular bronchiectasis. J Assoc Physicians India 1995;43:127-9.
471. Wong ML, Szkup P, Hopley MJ. Percutaneous embolotherapy for life-threatening hemoptysis. Chest 2002;121:95-102.
472. Thompson JW, Nguyen CD, Lazar RH, et al. Evaluation and management of hemoptysis in infants and children. A report of nine cases. Ann Otol Rhinol Laryngol 1996;105:516-20.
473. Barben JU, Ditchfield M, Carlin JB, et al. Major haemoptysis in children with cystic fibrosis: a 20-year retrospective study. J Cyst Fibros 2003;2:105-11.
474. Benhamou D, Muir JF, Raspaud C, et al. Long-term efficiency of home nasal mask ventilation in patients with diffuse bronchiectasis and severe chronic respiratory failure: a case- control study. Chest 1997;112:1259-66.
475. Gacouin A, Desrues B, Léna H, et al. Long-term nasal intermittent positive pressure ventilation (NIPPV) in sixteen consecutive patients with bronchiectasis: a retrospective study. Eur Respir J 1996;9:1246-50.
476. Simonds AK, Elliott MW. Outcome of domiciliary nasal intermittent positive pressure ventilation in restrictive and obstructive disorders. Thorax 1995;50:604-9.
477. Dupont M, Gacouin A, Lena H, et al. Survival of patients with bronchiectasis after the first ICU stay for respiratory failure. Chest 2004;125:1815-20.
478. Saynajakangas O, Keistinen T, et al. Bronchiectasis in Finland: trends in hospital treatment. Respir Med 1997;91:395-8.
479. Säynäjäkangas O, Keistinen T, Tuuponen T, et al. Evaluation of the incidence and age distribution of bronchiectasis from the Finnish hospital discharge register. Cent Eur J Public Health 1998;6:235-7.
480. Twiss J, Metcalfe R, Edwards E, et al. New Zealand national incidence of bronchiectasis "too high" for a developed country. Arch Dis Child 2005; 90:737-40.
481. Weycker D, Edelsberg J, Oster G, et al. Prevalence and economic burden of bronchiectasis. Am J Respir Crit Care Med 2004;169:A330.
482. Crofton J. Bronchiectasis. In: Crofton J, Douglas A, eds. Respiratory diseases. 3rd edn. Oxford: Blackwell Scientific 1981:417-30.
483. Martinez-Garcia MA, Soler-Cataluna JJ, Perpina-Tordera M, et al. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest 2007;132:1565-72.
484. Cazzola G, Valletta EA, Ciaffoni S, et al. Neutrophil function and humoral immunity in children with recurrent infections of the lower respiratory tract and chronic bronchial suppuration. Ann Allergy 1989;63:213-18.
485. Pettit SJ, Bourne H, Spickett GP. Survey of infection in patients receiving antibody replacement treatment for immune deficiency. J Clin Pathol 2002;55:577-80.
486. Hilton AM, Doyle L. Immunological abnormalities in bronchiectasis with chronic bronchial suppuration. Br J Dis Chest 1978;72:207-16.
487. NIfCE. Chronic obstractive pulmonary disease: national clinical guideline for management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004;59(Suppl 1):1-232.
488. Wong You Cheong JJ, Leahy BC, Taylor PM, et al. Airways obstruction and bronchiectasis: correlation with duration of symptoms and extent of bronchiectasis on computed tomography. Clin Radiol 1992;45:256-9.
489. Pappas JN, Donnelly LF, Frush DP. Reduced frequency of sedation of young children with multisection helical CT. Radiology 2000;215:897-9.
490. Sharples LD, Edmunds J, Bilton D, et al. A randomised controlled crossover trial of nurse practitioner versus doctor led outpatient care in a bronchiectasis clinic. Thorax 2002;57:661-6. (Pubitemid 34864519)
491. Bott J, Moran F. Physiotherapy and NIPPV. In: Simonds AK, ed. Non-invasive respiratory support. London: Chapman and Hall, 1995:133-42.
492. Kolbe J, Wells A, Ram FS. Inhaled steroids for bronchiectasis. Cochrane Database Syst Rev 2000(2):CD000996.
493. Lasserson T, Holt K, Greenstone M. Oral steroids for bronchiectasis (stable and acute exacerbations). Cochrane Database Syst Rev 2001(4):CD001262.
494. Corless JA, Warburton CJ. Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis. Cochrane Database Syst Rev 2000(4):CD002174.
495. BNF for children, London: BMJ Publishing Group, RPS Publishing and RCPCH Publications, 2009.
496. Amsden GW. Anti-inflammatory effects of macrolides: an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother 2005;55:10-21.
497. Parnham MJ. Immunomodulatory effects of antimicrobials in the therapy of respiratory tract infections. Curr Opin Infect Dis 2005;18:125-31.
498. Hatipoglu U, Rubinstein I. Low-dose, long-term macrolide therapy in asthma: an overview. Clin Mol Allergy 2004;2:4.
499. Schultz MJ. Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis. J Antimicrob Chemother 2004;54:21-8.
500. BNF. London: BMJ Publishing Group, 2010.
501. Evans DJ, Bara AI, Greenstone M. Prolonged antibiotics for purulent bronchiectasis. Cochrane Database Syst Rev 2003(4):CD001392.
502. Henrichfreise B, Wiegand I, Pfister W, et al. Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation. Antimicrob Agents Chemother 2007;51:4062-70.
503. Radberg G, Nilsson LE, Svensson S. Development of quinolone-imipenem cross resistance in Pseudomonas aeruginosa during exposure to ciprofloxacin. Antimicrob Agents Chemother 1990;34:2142-7.
504. Gaillard EA, Carty H, Heaf D, et al. Reversible bronchial dilatation in children: Comparison of serial high-resolution computer tomography scans of the lungs. Eur J Radiol 2003;47:215-20.
505. Equi A, Balfour-Lynn IM, Bush A, et al. Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. Lancet 2002;360:978-84.
506. Saiman L, Marshall BC, Mayer-Hamblett N, et al. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 2003;290:1749-56.
507. Hoiby N. Diffuse panbronchiolitis and cystic fibrosis: East meets West. Thorax 1994;49:531-2.
508. Twiss J, Byrnes C, Johnson R, et al. Nebulised gentamicin-suitable for childhood bronchiectasis. Int J Pharm 2005;295:113-19.
509. Ramsey BW, Pepe MS, Quan JM, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med 1999;340:23-30.
510. Gruson D, Hilbert G, Vargas F, et al. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilatorassociated pneumonia. Crit Care Med 2003;31:1908-14.
511. Hoffken G, Niederman MS. Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest 2002;122:2183-96.
512. Hughes MG, Evans HL, Chong TW, et al. Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward. Crit Care Med 2004;32:53-60.
513. Pechere JC. Rotating antibiotics in the intensive care unit: feasible, apparently beneficial, but questions remain. Crit Care 2002;6:9-10.
514. Raymond DP, Pelletier SJ, Crabtree TD, et al. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med 2001;29:1101-8.
515. Ho PL, Chan KN, Ip MS, et al. The effect of Pseudomonas aeruginosa infection on clinical parameters in steady-state bronchiectasis. Chest 1998;114:1594-8.
516. Anon. Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society. Thorax 2000;55:210-18.
517. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416.
518. Agasthian T, Deschamps C, Trastek VF, et al. Surgical management of bronchiectasis. Ann Thorac Surg 1996;62:976-8.
519. Dogan R, Alp M, Kaya S, et al. Surgical treatment of bronchiectasis: a collective review of 487 cases. Thorac Cardiovasc Surg 1989;37:183-6.
520. Fujimoto T, Hillejan L, Stamatis G. Current strategy for surgical management of bronchiectasis. Ann Thorac Surg 2001;72:1711-15.
521. George SA, Leonardi HK, Overholt RH. Bilateral pulmonary resection for bronchiectasis: a 40-year experience. Ann Thorac Surg 1979;28:48-53.
522. Halezeroglu S, Keles M, Uysal A, et al. Factors affecting postoperative morbidity and mortality in destroyed lung. Ann Thorac Surg 1997;64:1635-8.
523. Borrie J, Lichter I. Surgical treatment of bronchiectasis: ten-year survey. BMJ 1965;5467:908-12.
524. Chiang TC, Kok VK, Tu HH, et al. Surgical treatment of bronchiectasis: 10 years' experience. Zhonghua Yi Xue Za Zhi (Taipei) 1999;62:690-4.
525. Ashour M, Al Kattan K, Rafay MA, et al. Current surgical therapy for bronchiectasis. World J Surg 1999;23:1096-104.
526. Ashour M, Al Kattan KM, Jain SK, et al. Surgery for unilateral bronchiectasis: results and prognostic factors. Tuberc Lung Dis 1996;77:168-72.
527. Laros CD, Van den Bosch JM, Westermann CJ, et al. Resection of more than 10 lung segments. A 30-year survey of 30 bronchiectatic patients. J Thorac Cardiovasc Surg 1988;95:119-23.
528. Vejlsted H, Hjelms E, Jacobsen O. Results of pulmonary resection in cases of unilateral bronchiectasis. Scand J Thorac Cardiovasc Surg 1982;16:81-5.
529. Leger P, Bedicam JM, Cornette A, et al. Nasal intermittent positive pressure ventilation. Long-term follow-up in patients with severe chronic respiratory insufficiency. Chest 1994;105:100-5.
530. Anon. International guidelines for the selection of lung transplant candidates. The American Society for Transplant Physicians (ASTP)/American Thoracic Society(ATS)/European Respiratory Society(ERS)/International Society for Heart and Lung Transplantation(ISHLT). Am J Respir Crit Care Med 1998;158:335-9.
531. Sweet SC. Pediatric lung transplantation: update 2003. Pediatr Clin North Am 2003;50:1393-417, ix.
532. O'Driscoll BR, Howard LS, Davison AG. BTS guideline for emergency oxygen use in adult patients. Thorax 2008;63(Suppl 6):vi1-68.
533. Dodd ME, Abbott J, Maddison J, et al. Effect of tonicity of nebulised colistin on chest tightness and pulmonary function in adults with cystic fibrosis. Thorax 1997;52:656-8.
534. Cunningham S, Prasad A, Collyer L, et al. Bronchoconstriction following nebulised colistin in cystic fibrosis. Arch Dis Child 2001;84:432-3.
535. Webb AK, Dodd M, Bush A. Nebulised antibiotics in cystic fibrosis and non-CF bronchiectasis in childrena adults. In: Boe J, O'Driscoll R, Dennis J, eds. Practical handbook of nebuliser therapy. London: Martin Dunitz, 2004.
536. Webb AK, Dodd ME. Nebulised antibiotics for adults with cystic fibrosis. Thorax 1997;52(Suppl 2):S69-7.
537. Boe J, Dennis JH, O'Driscoll BR, et al. European Respiratory Society Guidelines on the use of nebulizers. Eur Respir J 2001;18:228-42.
538. British Thoracic Society. BTS guidelines on current best practice for nebuliser treatment. Thorax 1997;52(Suppl 2):S1-106.
539. Cystic Fibrosis Trust. Antibiotic treatment for cystic fibrosis: London: Cystic Fibrosis Trust, 2002.
540. Lannefors L, Heslop K, Teirlinck C. Nebuliser systems, contamination, microbial risks, cleaning and effect on function. Eur Respir Rev 2000;10:571-5.
541. Hammond D. Home intravenous antibiotics: the safety factor. J Infus Nurs 1998;21:81-95.
542. Marco T, Asensio O, Bosque M, et al. Home intravenous antibiotics for cystic fibrosis. Cochrane Database Syst Rev 2000(4):CD001917.
543. Wolter JM, Bowler SD, Nolan PJ, et al. Home intravenous therapy in cystic fibrosis: a prospective randomized trial examining clinical, quality of life and cost aspects. Eur Respir J 1997;10:896-900.
544. Horn CK, Conway SP. Candidaemia: risk factors in patients with cystic fibrosis who have totally implantable venous access systems. J Infect 1993;26:127-32.
545. Burdon J, Conway SP, Murchan P, et al. Five years' experience of PAS Port intravenous access system in adult cystic fibrosis. Eur Respir J 1998;12:212-16.
546. Kock HJ, Pietsch M, Krause U, et al. Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems. World J Surg 1998;22:12-16.
547. Di Carlo I, Cordio S, La Greca G, et al. Totally implantable venous access devices implanted surgically: a retrospective study on early and late complications. Arch Surg 2001;136:1050-3.
548. Stockton P, Cowperthwaite C, Meaden B, et al. Results of extending the flush time interval of Portacaths in CF patients. Thorax 1999;54(Suppl 3):A67.
549. Rosenfeld M, Emerson J, Accurso F, et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol 1999;28:321-8.